In first oncology expert meeting under Makary, FDA spotlights cancer drugs from J&J, Pfizer, Roche and UroGen

8th May 2025 Uncategorised 0

The head of the FDA’s oncology department, Richard Pazdur, M.D., is now the only FDA center director left from the prior administration, so the biopharma industry will be looking eagerly for signs of policy consistency from the upcoming public meeting.

More: In first oncology expert meeting under Makary, FDA spotlights cancer drugs from J&J, Pfizer, Roche and UroGen
Source: fierce